Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney Cancer.
Siech C, de Angelis M, Jannello LMI, Di Bello F, Rodriguez Peñaranda N, Goyal JA, Tian Z, Saad F, Shariat SF, Puliatti S, Longo N, de Cobelli O, Briganti A, Hoeh B, Mandel P, Kluth LA, Chun FKH, Karakiewicz PI. Siech C, et al. Among authors: hoeh b. Crit Care Med. 2025 Jan 1;53(1):e132-e139. doi: 10.1097/CCM.0000000000006496. Epub 2024 Nov 14. Crit Care Med. 2025. PMID: 39774205
Adjuvant therapy with pembrolizumab in renal cell carcinoma: real-world experiences from a retrospective, multi-institutional cohort.
Mattigk A, Cano Garcia C, Klümper N, Cox A, Hahn O, Junker K, Erdmann K, Schmucker P, Flegar L, Zengerling F, Banek S, Ellinger J, Buerk BT, Huber J, Kalogirou C, Zeuschner P, Hoeh B. Mattigk A, et al. Among authors: hoeh b. Urol Int. 2024 Dec 24:1-21. doi: 10.1159/000543278. Online ahead of print. Urol Int. 2024. PMID: 39719131
Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer.
Wenzel M, Hoeh B, Humke C, Welte M, Cano Garcia C, Siech C, Saad F, Karakiewcz PI, Tilki D, Steuber T, Graefen M, Traumann M, Chun FKH, Mandel P. Wenzel M, et al. Among authors: hoeh b. JBMR Plus. 2024 Nov 26;9(1):ziae157. doi: 10.1093/jbmrpl/ziae157. eCollection 2025 Jan. JBMR Plus. 2024. PMID: 39677923 Free PMC article.
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand Therapy.
Wenzel M, Koll F, Hoeh B, Humke C, Reis H, Wild P, Steuber T, Graefen M, Tilki D, Sabet A, Gröner D, Chun FKH, Mandel P. Wenzel M, et al. Among authors: hoeh b. JCO Precis Oncol. 2024 Dec;8:e2400645. doi: 10.1200/PO-24-00645. Epub 2024 Dec 6. JCO Precis Oncol. 2024. PMID: 39642328
118 results